← FDA Drug Approvals (Drugs@FDA)
GLUCAGON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-09-15
Drug application
- FDA Application #
ANDA218813- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GLUCAGON
- Generic name
- GLUCAGON
- Active ingredients
- GLUCAGON
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- CIPLA
- Manufacturer
- Cipla USA Inc.
- First approval
- 2025-09-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown